In vivo new bone formation by direct transfer of adenoviral-mediated bone morphogenetic protein-4 gene
- 4 October 2002
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 298 (1) , 121-127
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Development of an MFG-Based Retroviral Vector System for Secretion of High Levels of Functionally Active Human BMP4Molecular Therapy, 2001
- Orthopedic applications of gene therapyJournal of Orthopaedic Science, 2001
- Osteoinduction by Bone Morphogenetic Protein-2 via Adenoviral Vector under Transient ImmunosuppressionBiochemical and Biophysical Research Communications, 2000
- Persistence of an [E1-, Polymerase-] Adenovirus Vector Despite Transduction of a Neoantigen into Immune-Competent MiceHuman Gene Therapy, 1999
- Blunting of immune responses to adenoviral vectors in mouse liver and lung with CTLA4IgGene Therapy, 1998
- Bone morphogenetic protein gene therapy for the induction of spinal arthrodesisNeurosurgical Focus, 1998
- Liver-Directed Gene Transfer in Non-Human PrimatesHuman Gene Therapy, 1997
- Bone Morphogenetic Protein-2 Inhibits Terminal Differentiation of Myogenic Cells by Suppressing the Transcriptional Activity of MyoD and MyogeninExperimental Cell Research, 1997
- Bone morphogenetic protein-4The International Journal of Biochemistry & Cell Biology, 1996
- The bone morphogenetic protein family and osteogenesisMolecular Reproduction and Development, 1992